Reaching the theoretical herd immunity threshold in Iquitos, Peru: are seroprevalence data enough?

doi:10.1016/S2214-109X(21)00203-5

Comment

. 2021 Jul;9(7):e881-e882.

doi: 10.1016/S2214-109X(21)00203-5. Epub 2021 May 19.

Reaching the theoretical herd immunity threshold in Iquitos, Peru: are seroprevalence data enough?

Stella M Chenet¹, Rafael Tapia-Limonchi²

Affiliations

¹ Instituto de Enfermedades Tropicales, Universidad Nacional Toribio Rodríguez de Mendoza de Amazonas, Chachapoyas, Peru. Electronic address: schenet@asu.edu.
² Instituto de Enfermedades Tropicales, Universidad Nacional Toribio Rodríguez de Mendoza de Amazonas, Chachapoyas, Peru.

PMID: 34022149
PMCID: PMC8133767
DOI: 10.1016/S2214-109X(21)00203-5

Comment

Reaching the theoretical herd immunity threshold in Iquitos, Peru: are seroprevalence data enough?

Stella M Chenet et al. Lancet Glob Health. 2021 Jul.

. 2021 Jul;9(7):e881-e882.

doi: 10.1016/S2214-109X(21)00203-5. Epub 2021 May 19.

Authors

Stella M Chenet¹, Rafael Tapia-Limonchi²

Affiliations

¹ Instituto de Enfermedades Tropicales, Universidad Nacional Toribio Rodríguez de Mendoza de Amazonas, Chachapoyas, Peru. Electronic address: schenet@asu.edu.
² Instituto de Enfermedades Tropicales, Universidad Nacional Toribio Rodríguez de Mendoza de Amazonas, Chachapoyas, Peru.

PMID: 34022149
PMCID: PMC8133767
DOI: 10.1016/S2214-109X(21)00203-5

No abstract available

PubMed Disclaimer

Conflict of interest statement

We declare no competing interests.

Comment on

Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Peru in July and August, 2020: a population-based study.
Álvarez-Antonio C, Meza-Sánchez G, Calampa C, Casanova W, Carey C, Alava F, Rodríguez-Ferrucci H, Quispe AM. Álvarez-Antonio C, et al. Lancet Glob Health. 2021 Jul;9(7):e925-e931. doi: 10.1016/S2214-109X(21)00173-X. Epub 2021 May 19. Lancet Glob Health. 2021. PMID: 34022148 Free PMC article.

Cited by

Diagnostic performance of four lateral flow immunoassays for COVID-19 antibodies in Peruvian population.
Calderon-Flores R, Caceres-Cardenas G, Alí K, De Vos M, Emperador D, Cáceres T, Eca A, Villa-Castillo L, Albertini A, Sacks JA, Ugarte-Gil C. Calderon-Flores R, et al. PLOS Glob Public Health. 2023 Jun 2;3(6):e0001555. doi: 10.1371/journal.pgph.0001555. eCollection 2023. PLOS Glob Public Health. 2023. PMID: 37267241 Free PMC article.
Seropositivity of SARS-CoV-2 in the Population of Kazakhstan: A Nationwide Laboratory-Based Surveillance.
Semenova Y, Kalmatayeva Z, Oshibayeva A, Mamyrbekova S, Kudirbekova A, Nurbakyt A, Baizhaxynova A, Colet P, Glushkova N, Ivankov A, Sarria-Santamera A. Semenova Y, et al. Int J Environ Res Public Health. 2022 Feb 17;19(4):2263. doi: 10.3390/ijerph19042263. Int J Environ Res Public Health. 2022. PMID: 35206453 Free PMC article.
Phylodynamic of SARS-CoV-2 during the second wave of COVID-19 in Peru.
Justo Arevalo S, Uribe Calampa CS, Jimenez Silva C, Quiñones Aguilar M, Bouckaert R, Rebello Pinho JR. Justo Arevalo S, et al. Nat Commun. 2023 Jun 15;14(1):3557. doi: 10.1038/s41467-023-39216-8. Nat Commun. 2023. PMID: 37322028 Free PMC article.
Epidemiological Analysis of COVID-19 Cases in Native Amazonian Communities from Peru.
Pajuelo-Reyes C, Valencia HJ, Montenegro CC, Quezada E, Gonzales L, Cruz N, Canelo C, Ordinola C, Maicelo Quintana JL, Tejedo JR, Tapia-Limonchi R, Chenet SM. Pajuelo-Reyes C, et al. Epidemiologia (Basel). 2021 Oct 9;2(4):490-501. doi: 10.3390/epidemiologia2040034. Epidemiologia (Basel). 2021. PMID: 36417212 Free PMC article.

References

1. Ng KW, Faulkner N, Cornish GH, et al. Preexisting and de novo humoral immunity to SARS-CoV-2 in humans. Science. 2020;370:1339–1343. - PMC - PubMed
1. Sagara I, Woodford J, Dicko A, et al. SARS-CoV-2 seroassay optimization and performance in a population with high background reactivity in Mali. medRxiv. 2021 doi: 10.1101/2021.03.08.21252784. published online March 12. (preprint). - DOI - PMC - PubMed
1. Anderson EM, Goodwin EC, Verma A, et al. Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection. Cell. 2021;184:1858–1864.e10. - PMC - PubMed
1. Álvarez-Antonio C, Meza-Sánchez G, Calampa C, et al. Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Peru in July and August, 2020: a population-based study. Lancet Glob Health. 2021 doi: 10.1016/S2214-109X(21)00173-X. published online May 19. - DOI - PMC - PubMed
1. Ministry of Health of Peru Situación actual COVID19 Perú 2020. Dec 31, 2020. https://www.dge.gob.pe/portal/docs/tools/coronavirus/coronavirus311220.pdf

Uncited References

1. Gomes MGM, Corder RM, King JG, et al. Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold. medRxiv. 2020 doi: 10.1101/2020.04.27.20081893. published online May 21. (preprint). - DOI - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations

[1] Ng KW, Faulkner N, Cornish GH, et al. Preexisting and de novo humoral immunity to SARS-CoV-2 in humans. Science. 2020;370:1339–1343. - PMC - PubMed

[2] Ng KW, Faulkner N, Cornish GH, et al. Preexisting and de novo humoral immunity to SARS-CoV-2 in humans. Science. 2020;370:1339–1343. - PMC - PubMed

[3] Sagara I, Woodford J, Dicko A, et al. SARS-CoV-2 seroassay optimization and performance in a population with high background reactivity in Mali. medRxiv. 2021 doi: 10.1101/2021.03.08.21252784. published online March 12. (preprint). - DOI - PMC - PubMed

[4] Sagara I, Woodford J, Dicko A, et al. SARS-CoV-2 seroassay optimization and performance in a population with high background reactivity in Mali. medRxiv. 2021 doi: 10.1101/2021.03.08.21252784. published online March 12. (preprint). - DOI - PMC - PubMed

[5] Anderson EM, Goodwin EC, Verma A, et al. Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection. Cell. 2021;184:1858–1864.e10. - PMC - PubMed

[6] Anderson EM, Goodwin EC, Verma A, et al. Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection. Cell. 2021;184:1858–1864.e10. - PMC - PubMed

[7] Álvarez-Antonio C, Meza-Sánchez G, Calampa C, et al. Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Peru in July and August, 2020: a population-based study. Lancet Glob Health. 2021 doi: 10.1016/S2214-109X(21)00173-X. published online May 19. - DOI - PMC - PubMed

[8] Álvarez-Antonio C, Meza-Sánchez G, Calampa C, et al. Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Peru in July and August, 2020: a population-based study. Lancet Glob Health. 2021 doi: 10.1016/S2214-109X(21)00173-X. published online May 19. - DOI - PMC - PubMed

[9] Ministry of Health of Peru Situación actual COVID19 Perú 2020. Dec 31, 2020. https://www.dge.gob.pe/portal/docs/tools/coronavirus/coronavirus311220.pdf

[10] Ministry of Health of Peru Situación actual COVID19 Perú 2020. Dec 31, 2020. https://www.dge.gob.pe/portal/docs/tools/coronavirus/coronavirus311220.pdf

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Reaching the theoretical herd immunity threshold in Iquitos, Peru: are seroprevalence data enough?

Affiliations

Reaching the theoretical herd immunity threshold in Iquitos, Peru: are seroprevalence data enough?

Authors

Affiliations

Conflict of interest statement

Comment on

Similar articles

Cited by

References

Uncited References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources